Şizofrenili Olgularda Düşük Dereceli İnflamasyon, Lipid Düzeyleri ve Özkıyım Arasındaki İlişki

Year 2018, Volume: 1 Issue: 2, 57 - 63, 10.09.2018

Okan Ekinci Aslı Ekinci

https://doi.org/10.33713/egetbd.447360

Abstract

Sonuç:
bu çalışma şizofrenili olgularda CRP ile şu anki özkıyımla ilişkisini bildiren
ve CRP nin özkıyım girişimi için bir biyolojik belirteç olabileceğini öne süren
ilk çalışmadır. CRP ve diğer inflamasyon belirteçlerinin şizofrenide özkıyım
davranışındaki kesin rolleri belirlemek için daha geniş örneklemli ileriye dönük desende çalışmalara ihtiyaç
bulunmaktadır.

Bulgular:  Özkıyım
girişimi olan şizofrenili olgularda olmayanlara kıyasla CRP ve NLR değerlerinin
karıştırıcı faktörler kontrol edildikten sonra dahi anlamlı olarak yüksek
olduğu bulundu. Regresyon analizi iki değişkenin şu anki özkıyım girişimini
öngördürdüğünü gösterdi: A)Geçmiş özkıyım öyküsü B)CRP

Yöntem:
Çalışma grubu 128 hastadan oluştu. Bunlardan 24 ü özkıyım girişimi olan 104 ise
özkıyım girişimi olmayan hastalardan oluşuyordu. NLR, CRP, PLR ve lipid
değerleri geriye dönük olarak hastaların dijital dosya kayıtlarından elde
edildi.

Amaç: Özkıyım
davranışının patofizyolojisinde inflamasyon ve lipid metabolizmasının rolüne
ilgi son yıllarda artmaktadır. Nötrofil lenfosit oranı (NLR) ve Creaktif
protein (CRP) düşük dereceli inflamasyonun güvenilir ve yeni belirteçleri
olarak sunulmaktadır. CRP ve NLR nin şizofrenili olgularda değiştiği ve
depresif bozukluklu olgularda ise özkıyım ile ilişkili olduğu bildirilmektedir.
Bu çalışmada şizofrenili olgularda CRP, NLR ve lipid değerlerinin özkıyım
davranışı ile ilişkisini araştırmayı amaçladık.

Keywords

C reaktif protein, Nötrofil lenfosit oranı, şizofreni, lipid

References

• 1. Popovic D, Benabarre A, Crespo JM, et al. Risk Factors for Suicide in Schizophrenia: Systematic Review and Clinical Recommendations. Acta Psychiatr Scand. 2014; 130(6): 418-26.2. Alvarado-Esquivel C, Sanchez-Anguiano LF, AmaudGil CA, Hernandez-Tinoco J, Molina Espinoza LF, Rabago-Sanchez E. Socio-Demographic, Clinical and Behavioral Characteristics Associated with a History of Suicide Attempts among Psychiatric Outpatients: A case Control Study in a Northern Mexican City. Int J Biomed Sci. 2014; 10(1): 61-8. 45.3. Gupta S, Black DW, Arndt S, Hubbard WC, Andreasen NC. Factors Associated with Suicide Attempts Among Patient with Schizophrenia. Psychiatric Services. 1998; 49(10): 1353-5.4. Westermeyer JF, Harrow M, Marengo JT. Risk for suicide in schizophrenia and other psychotic and nonpsychotic disorders. J Nerv Ment Dis 1991;179:259-66.5. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 2005;62:247-53.6. Devlet İstatistik Enstitüsü Başbakanlık. Özkıyım İstatistikleri 2002. Ankara: Devlet İstatistik Enstitüsü Matbaası; 2002.7. Janelidze S, Mattei D, Westrin A, Tra ¨skman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011;25:335–9.8. Black C, Miller BJ. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry. 2015;78(1):28-37 9. Courtet P, Jaussent I, Genty C, Dupuy AM, Guillaume S, Ducasse D, Olié E (2015) Increased CRP levels may be a trait marker of suicidal attempt. Eur Neuropsychopharmacol. 25(10):1824-1831.10. Ekinci O, Ekinci A. The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio. Nord J Psychiatry. 2017;71(8):574-580.11. Misiak B, Kiejna A, Frydecka D. Higher total cholesterol level is associated with suicidal ideation in first-episode schizophrenia females.Psychiatry Res. 2015; 226(1):383-8.12. Baek JH, Kang ES, Fava M, et al. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2014; 51:113–118.13. De Graca Cantarelli M, Tramontina AC, Leite MC, Goncalves CA. Potential neuro-chemical links between cholesterol and suicidal behavior. Psychiatry Res. 2014;220:745–51. 14. Park S, Yi KK, Na R, Lim A, Hong JP. No association between serum cholesterol and death by suicide in patients with schizophrenia, bipolar affective disorder, or major depressive disorder. Behavioral and Brain Functions 2013; 9: 4515. Montross LP, Zisook S, Kasckow J. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann. Clin. Psychiatry 17, 173–182 (2005).16. Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P. Suicide in schizophrenia. Expert Rev Neurother. 2010; 10(7):1153-64.17. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatrica Scandinavica 2003; 108, 208–214.18. Marcinko D, Popovic-Knapic V, Franic T, et al. Association of cholesterol and socio-demographic parameters with suicidality in the male patients with schizophrenia. Psychiatria Danub. 2008; 20: 390–395.19. Diaz-Sastre Carmen, Baca-Garcia Enrique, Perez-Rodriguez Maria M,et al. Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and non attempters. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31:901–5.20. De Leon J, Mallory P, Maw L, Susce MT, Perez-Rodriguez MM, Baca-Garcia E. Lack of replication of the association of low serum cholesterol and attempted suicide in another country raises more questions. Ann Clin Psychiatry. 2011;23:163–70.21. da Graça Cantarelli M, Nardin P, Buffon A, et al. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord 2015; 172: 403-409.22. Vuksan-Cusa B, Marcinko D, Nad S, Jakovljevic M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:109–1223. Mukamal KJ, Wee CC, Miller M. BMI and rates of suicide in the United States: an ecological analysis. Obesity (Silver Spring). 2009; 17(10):1946-50.24. O’Donovan A, Rush G, Hoatam G, et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety 2013;30: 307–14.25. Pandey GN, Rizavi HS, Ren X, et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012; 46: 57-63.26. Tonelli LH, Stiller J, Rujescu D, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008; 117: 198-206.27. Maes M. Depression is an inflammatory disease, but cellmediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35: 664–67528. Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46–56. 29. Dickerson SS, Gable SL, Irwin MR, et al. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Psychol Sci 2009;20:1237–1244.30. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psych Bull 2004;130:355–39131. Faugere M, Micoulaud-Franchi JA, Faget-Agius C, Lançon C, Cermolacce M, Richieri R. High C-reactive protein levels are associated with depressive symptoms in schizophrenia. J Affect Disord. 2018; 225:671-675.32. Akanji AO, Ohaeri JU, Al-Shammri S, Fatania HR. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Res 2009;169:56–61. 33. Barzilay R, Lobel T, Krivoy A, Shlosberg D, Weizman A, Katz N. Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior.Eur Psychiatry. 2016 ;31:8-12.34. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 2007;93:261–5.35. Dickerson F, Stallings C, Origoni A, et al. Creactive protein is elevated in schizophrenia. Schizophr Res 2013; 143:198– 202. 36. Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res 2007;149:267–71.37. Fawzi MH, Fawzi MM, Fawzi MM, Said NS. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiatry Res 2011;190:91–7.38. Kulaksizoglu B, Kulaksizoglu S. Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia.Neuropsychiatr Dis Treat. 2016; 12:1999-2005. 39. Yüksel RN, Ertek IE, Dikmen AU, Göka E. High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters. Nord J Psychiatry. 2018; 12:1-5.